construction of aav-rat-il4 and evaluation of its modulating effect on aβ (1-42)-induced proinflammatory cytokines in primary microglia and the b92 cell line by quantitative pcr assay

results aβ (1-42) stimulated the production of the proinflammatory cytokines il6, il1β, tnfα, and il18 in both the primary microglia cell culture and the b92 cell line. both the raav-il4 construct and the ril-4 protein were found to inhibit production of the most important aβ (1-42)-induced proinflammatory cytokine mrnas in the two types of cells with different patterns. conclusions it seems that the new construct can serve as an appropriate option in the modulation of aβ-induced proinflammatory cytokine gene expression and microglia activation in patients affected by ad. background interleukin-4 (il-4), as the most prominent anti-inflammatory cytokine, plays an important role in modulating microglial activation and inflammatory responses in alzheimer’s disease (ad), a chronic inflammatory disorder. objectives the current study aimed to develop a new recombinant adeno-associated viral (raav) vector that delivers il-4 and then assess the counterbalancing effect of the new construct along with recombinant il-4 (ril-4) protein in in-vitro models of ad. materials and methods the raav-il4 was originally prepared and then employed along with ril-4 protein to counter amyloid β (1-42)-induced proinflammatory cytokines in a primary microglia cell culture and the b92 rat microglia continuous cell line, using relative real-time pcr assay.